Literature DB >> 17204525

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial.

Esther B Baart1, Elena Martini, Marinus J Eijkemans, Diane Van Opstal, Nicole G M Beckers, Arie Verhoeff, Nicolas S Macklon, Bart C J M Fauser.   

Abstract

BACKGROUND: To test whether ovarian stimulation for in-vitro fertilization (IVF) affects oocyte quality and thus chromosome segregation behaviour during meiosis and early embryo development, preimplantation genetic screening of embryos was employed in a prospective, randomized controlled trial, comparing two ovarian stimulation regimens.
METHODS: Infertile patients under 38 years of age were randomly assigned to undergo a mild stimulation regimen using gonadotrophin-releasing hormone (GnRH) antagonist co-treatment (67 patients), which does not disrupt secondary follicle recruitment, or a conventional high-dose exogenous gonadotrophin regimen and GnRH agonist co-treatment (44 patients). Following IVF, embryos were biopsied at the eight-cell stage and the copy number of 10 chromosomes was analysed in 1 or 2 blastomeres.
RESULTS: The study was terminated prematurely, after an unplanned interim analysis (which included 61% of the planned number of patients) found a lower embryo aneuploidy rate following mild stimulation. Compared with conventional stimulation, significantly fewer oocytes and embryos were obtained following mild stimulation (P < 0.01 and < 0.05, respectively). Consequently, both regimens generated on average a similar number (1.8) of chromosomally normal embryos. Differences in rates of mosaic embryos suggest an effect of ovarian stimulation on mitotic segregation errors.
CONCLUSIONS: Future ovarian stimulation strategies should avoid maximizing oocyte yield, but aim at generating a sufficient number of chromosomally normal embryos by reduced interference with ovarian physiology.

Entities:  

Mesh:

Year:  2007        PMID: 17204525     DOI: 10.1093/humrep/del484

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  103 in total

1.  Contributing factors for the incidence of aneuploidy in older patients undergoing intracytoplasmic sperm injection cycles.

Authors:  Daniela Paes de Almeida Ferreira Braga; Amanda S Setti; Rita de Cássia S Figueira; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2012-05-29       Impact factor: 3.412

2.  Is aneuploidy a defense mechanism to prevent maternity later in a woman's life.

Authors:  Marc-André Sirard
Journal:  J Assist Reprod Genet       Date:  2011-03       Impact factor: 3.412

3.  Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?

Authors:  Sanghoon Lee; Kutluk Oktay
Journal:  Fertil Steril       Date:  2012-07-06       Impact factor: 7.329

4.  Mild IVF using GnRH agonist long protocol is possible: comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose.

Authors:  Sylvia Fernández-Shaw; Nuria Pérez Esturo; Rosa Cercas Duque; Isabel Pons Mallol
Journal:  J Assist Reprod Genet       Date:  2009-01-17       Impact factor: 3.412

5.  A greater number of euploid blastocysts in a given cohort predicts excellent outcomes in single embryo transfer cycles.

Authors:  Scott Morin; Katherine Melzer-Ross; David McCulloh; Jamie Grifo; Santiago Munné
Journal:  J Assist Reprod Genet       Date:  2014-06       Impact factor: 3.412

Review 6.  Preimplantation genetic screening: does it help or hinder IVF treatment and what is the role of the embryo?

Authors:  Kim Dao Ly; Ashok Agarwal; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2011-07-09       Impact factor: 3.412

7.  Mild ovarian stimulation for in vitro fertilization: one perspective from the USA.

Authors:  Valerie L Baker
Journal:  J Assist Reprod Genet       Date:  2013-02       Impact factor: 3.412

8.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

9.  Predicting aneuploidy in human oocytes: key factors which affect the meiotic process.

Authors:  L Gianaroli; M C Magli; G Cavallini; A Crippa; A Capoti; S Resta; F Robles; A P Ferraretti
Journal:  Hum Reprod       Date:  2010-07-08       Impact factor: 6.918

Review 10.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.